JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms

Wanlong Ma; Hagop Kantarjian; Xi Zhang; Xiuqiang Wang; Zhong Zhang; Chen-Hsiung Yeh; Susan O'Brien; Francis Giles; Jean Marie Bruey; Maher Albitar

doi:10.1371/journal.pone.0012165

Loading metrics

Open Access

Peer-reviewed

Research Article

JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms

Wanlong Ma,

Affiliation Department of Hematology/Oncology, Quest Diagnostics Nichols Institute, San Juan Capistrano, California, United States of America
⨯
Hagop Kantarjian,

Affiliation Department of Leukemia, M.D. Anderson Cancer Center, University of Texas, Houston, Texas, United States of America
⨯
Xi Zhang,

Affiliation Department of Hematology/Oncology, Quest Diagnostics Nichols Institute, San Juan Capistrano, California, United States of America
⨯
Xiuqiang Wang,

Affiliation Department of Hematology/Oncology, Quest Diagnostics Nichols Institute, San Juan Capistrano, California, United States of America
⨯
Zhong Zhang,

Affiliation Department of Hematology/Oncology, Quest Diagnostics Nichols Institute, San Juan Capistrano, California, United States of America
⨯
Chen-Hsiung Yeh,

Affiliation Department of Hematology/Oncology, Quest Diagnostics Nichols Institute, San Juan Capistrano, California, United States of America
⨯
Susan O'Brien,

Affiliation Department of Leukemia, M.D. Anderson Cancer Center, University of Texas, Houston, Texas, United States of America
⨯
Francis Giles,

Affiliation The Cancer Treatment & Research Center (CTRC) at the University of Texas Health Science Center, San Antonio, Texas, United States of America
⨯
Jean Marie Bruey,

Affiliation Department of Hematology/Oncology, Quest Diagnostics Nichols Institute, San Juan Capistrano, California, United States of America
⨯
Maher Albitar

* E-mail: maher.x.albitar@questdiagnostics.com

Affiliation Department of Hematology/Oncology, Quest Diagnostics Nichols Institute, San Juan Capistrano, California, United States of America
⨯

JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms

Wanlong Ma,
Hagop Kantarjian,
Xi Zhang,
Xiuqiang Wang,
Zhong Zhang,
Chen-Hsiung Yeh,
Susan O'Brien,
Francis Giles,
Jean Marie Bruey,
Maher Albitar

Published: August 13, 2010
https://doi.org/10.1371/journal.pone.0012165

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Mutation detection
Is the Subject Area "Mutation detection" applicable to this article?

Thanks for your feedback.
Point mutation
Is the Subject Area "Point mutation" applicable to this article?

Thanks for your feedback.
Immunoprecipitation
Is the Subject Area "Immunoprecipitation" applicable to this article?

Thanks for your feedback.
Mutation
Is the Subject Area "Mutation" applicable to this article?

Thanks for your feedback.
Reverse transcriptase-polymerase chain reaction
Is the Subject Area "Reverse transcriptase-polymerase chain reaction" applicable to this article?

Thanks for your feedback.
Direct sequencing
Is the Subject Area "Direct sequencing" applicable to this article?

Thanks for your feedback.
Deletion mutation
Is the Subject Area "Deletion mutation" applicable to this article?

Thanks for your feedback.
Messenger RNA
Is the Subject Area "Messenger RNA" applicable to this article?

Thanks for your feedback.